We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Rexahn Pharmaceuticals, Inc. | AMEX:RNN | AMEX | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 5.24 | 0.00 | 01:00:00 |
Delaware
|
001-34079
|
11-3516358
|
(State or Other Jurisdiction of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
15245 Shady Grove Road
Suite 455
Rockville, MD
|
20850
|
(Address of principal executive offices)
|
(Zip Code)
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Director
|
For
|
Withheld
|
Broker Non-Votes
|
|||
Chang H. Ahn
|
53,124,602
|
16,245,631
|
83,692,088
|
|||
Charles Beever
|
52,549,708
|
16,820,525
|
83,692,088
|
|||
Peter Brandt
|
52,563,361
|
16,806,872
|
83,692,088
|
|||
Mark Carthy
|
52,556,167
|
16,814,066
|
83,692,088
|
|||
Kwang Soo Cheong
|
52,969,552
|
16,400,681
|
83,692,088
|
|||
Richard J. Rodgers
|
52,561,774
|
16,808,459
|
83,692,088
|
|||
Peter Suzdak
|
52,548,811
|
16,821,422
|
83,692,088
|
For
|
Against
|
Abstain
|
||
130,898,861
|
4,983,500
|
17,179,960
|
For
|
Against
|
Abstain
|
||
48,512,254
|
5,736,371
|
15,121,608
|
(d) | Exhibits. |
Exhibit No.
|
Description
|
10.1
|
Rexahn Pharmaceuticals, Inc. 2013 Stock Option Plan, as Amended and Restated
|
REXAHN PHARMACEUTICALS, INC.
|
|||
Dated:
|
June 10, 2016
|
||
/s/ Peter Suzdak
|
|||
Peter Suzdak
|
|||
Chief Executive Officer
|
Exhibit No.
|
Description
|
Rexahn Pharmaceuticals, Inc. 2013 Stock Option Plan, as Amended and Restated
|
1 Year Rexahn Pharmaceuticals, Inc. Chart |
1 Month Rexahn Pharmaceuticals, Inc. Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions